- Home
- MGX vs FUSB Comparison
MGX vs FUSB Comparison
Compare MGX & FUSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGX
- FUSB
- Stock Information
- Founded
- MGX 2018
- FUSB 1952
- Country
- MGX United States
- FUSB United States
- Employees
- MGX N/A
- FUSB N/A
- Industry
- MGX
- FUSB Major Banks
- Sector
- MGX
- FUSB Finance
- Exchange
- MGX NYSE
- FUSB Nasdaq
- Market Cap
- MGX 62.1M
- FUSB 72.6M
- IPO Year
- MGX 2024
- FUSB N/A
- Fundamental
- Price
- MGX $2.08
- FUSB $12.72
- Analyst Decision
- MGX Strong Buy
- FUSB
- Analyst Count
- MGX 4
- FUSB 0
- Target Price
- MGX $13.00
- FUSB N/A
- AVG Volume (30 Days)
- MGX 916.2K
- FUSB 2.2K
- Earning Date
- MGX 08-13-2025
- FUSB 07-23-2025
- Dividend Yield
- MGX N/A
- FUSB 2.23%
- EPS Growth
- MGX N/A
- FUSB N/A
- EPS
- MGX N/A
- FUSB 1.28
- Revenue
- MGX $45,263,000.00
- FUSB $38,449,000.00
- Revenue This Year
- MGX N/A
- FUSB N/A
- Revenue Next Year
- MGX $11.75
- FUSB N/A
- P/E Ratio
- MGX N/A
- FUSB $9.95
- Revenue Growth
- MGX N/A
- FUSB N/A
- 52 Week Low
- MGX $1.23
- FUSB $9.75
- 52 Week High
- MGX $5.49
- FUSB $14.30
- Technical
- Relative Strength Index (RSI)
- MGX 62.36
- FUSB 47.81
- Support Level
- MGX $2.04
- FUSB $12.56
- Resistance Level
- MGX $2.47
- FUSB $13.23
- Average True Range (ATR)
- MGX 0.18
- FUSB 0.28
- MACD
- MGX 0.07
- FUSB -0.02
- Stochastic Oscillator
- MGX 61.76
- FUSB 27.14
About MGX METAGENOMI INC
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.
About FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.